GlassScriptPhysician profile
Scott J Piper
NPI 1194712976
$2,682.35
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.21 · 2020: $183 · 2021: $500 · 2022: $850 · 2023: $862 · 2024: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,102.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $973.54 | 2021-2024 | |
| Pfizer INC. | $395.71 | 2021-2024 | |
| Novo Nordisk INC | $211.40 | 2020-2023 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $171.46 | 2019-2022 | |
| Amgen INC. | $167.62 | 2021-2023 | Repatha |
| Allergan, INC. | $118.32 | 2020 | |
| Axsome Therapeutics, INC. | $99.42 | 2023 | Auvelity |
| Lilly USA, LLC | $93.32 | 2022-2024 | Mounjaro, Zepbound |
| Biohaven Pharmaceutical Holding Company LTD. | $86.27 | 2022 | |
| Exact Sciences Corporation | $78.67 | 2023-2024 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $68.72 | 2020-2022 | |
| Phathom Pharmaceuticals, INC. | $44.43 | 2024 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.17 | 2023 | Xifaxan, Trulance |
| Almatica Pharma LLC | $33.85 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $29.85 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $20.73 | 2024 | Veozah |
| Teva Pharmaceuticals USA, INC. | $19.63 | 2021 | |
| Idorsia Pharmaceuticals US INC | $17.74 | 2022 | |
| Glaxosmithkline, LLC. | $13.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Piper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.